BioStructures, LLC Receives 510(k) Clearance for Innovative Bioactive Bone Graft Putty and Bone Graft Extender. - KPLC 7 News, Lake Charles, Louisiana

BioStructures, LLC Receives 510(k) Clearance for Innovative Bioactive Bone Graft Putty and Bone Graft Extender.

  • HealthMore>>

  • FDA to propose e-cigarette regulations

    FDA to propose e-cigarette regulations

    © FDA© FDA
    The U.S. Food and Drug Administration is proposing long-awaited regulations governing the fast-growing electronic cigarette industry.More >>
    The U.S. Food and Drug Administration is proposing long-awaited regulations governing the fast-growing electronic cigarette industry.More >>
  • People seek out health info when famous person dies

    People seek out health info when famous person dies

    WEDNESDAY, April 23, 2014 (HealthDay News) -- The deaths of well-known people offer an opportunity to educate the general public about disease detection and prevention, a new study suggests. Researchers surveyed 1,400 American men and women after Apple co-founder Steve Jobs died of pancreatic cancer in 2011 and learned that more than one-third of them sought information about his cause of death or information about cancer in general soon after his death was reported. About 7 percent of th...More >>
    WEDNESDAY, April 23, 2014 (HealthDay News) -- The deaths of well-known people offer an opportunity to educate the general public about disease detection and prevention, a new study suggests. Researchers surveyed 1,400 American men and women after Apple co-founder Steve Jobs died of pancreatic cancer in 2011 and learned that more than one-third of them sought information about his cause of death or information about cancer in general soon after his death was reported. About 7 percent of th...More >>
  • 1 in 13 U.S. schoolkids takes psych meds

    1 in 13 U.S. schoolkids takes psych meds

    More than 7 percent of American schoolchildren are taking at least one medication for emotional or behavioral difficulties, a new government report shows.More >>
    More than 7 percent of American schoolchildren are taking at least one medication for emotional or behavioral difficulties, a new government report shows.More >>

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE BioStructures, LLC

NEWPORT BEACH, Calif., Feb. 18, 2014 /PRNewswire/ -- BioStructures, LLC, a privately held orthobiologics company, today announced that the United States Food and Drug Administration has granted 510(k) clearance for Bioactive Bone Graft Putty (Signafuse™).  Signafuse™ is indicated for the posterolateral spine, extremities and pelvis as well as a bone graft extender in the posterolateral spine.

Signafuse™ represents a new class of synthetic biomaterials designed for optimization of cell growth and bone formation.  Signafuse™ is comprised of a biphasic mineral and bioactive glass suspended in a resorbable polymer carrier. The patented polymer carrier gives Signafuse exceptional handling characteristics which allow the graft to be easily molded and shaped for the unique size of the bony defect.

Russell Cook, CEO of BioStructures said, "We are very pleased to receive FDA clearance for Signafuse™ Bioactive Bone Graft Putty.  This technology combines our proven biphasic mineral with our patented bioactive and polymer components.  We realize the orthobiologic market is crowded with a plethora of commodity offerings, so we wanted to develop a unique and effective device that brings excitement to the surgeon community as well as our distribution partners."

About BioStructures, LLC

BioStructures is a leading medical device company focused on developing innovative proprietary platforms in bioresorbable bone graft products for a broad range of spinal and orthopedic fusion procedures.  BioStructures' global mission is to develop and commercialize new and innovative products focused on improving bone regeneration and remodeling for related clinical procedures.  For additional information on BioStructures, please visit our website at www.biostructures.net

CONTACT: Russell Cook, CEO, 949-553-1717, rcook@biostructures.net.

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow